A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Authors:
- Isabel ConceiçãoICIsabel Conceição
- On behalf of the THAOS investigatorsOIOn behalf of the THAOS investigators
Open Access
- 22 June 2022
- journal article
- research article
- Published by Taylor & Francis in Amyloid
- Vol. 29 (4) , 228-236
Abstract
Hereditary transthyretin amyloidosis (ATTRv amyloidosis) results from pathogenic mutations in the transthyretin (TTR) gene. This analysis aimed to better understand ATTRv amyloidosis development in...Keywords
Funding Information
- Pfizer
This publication has 28 references indexed in Scilit:
- Update in the diagnosis and management of transthyretin familial amyloid polyneuropathyJournal of Neurology, 2014
- Description of transthyretin S50A, S52P and G47A mutations in familial amyloidosis polyneuropathyAmyloid, 2013
- Guideline of transthyretin-related hereditary amyloidosis for cliniciansOrphanet Journal of Rare Diseases, 2013
- The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodologyCurrent Medical Research and Opinion, 2012
- Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian familiesEuropean Journal of Neurology, 2009
- Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish populationAmyloid, 2008
- Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese familiesJournal of Medical Genetics, 2003
- Type I (Transthyretin Met30) Familial Amyloid Polyneuropathy in JapanArchives of Neurology, 2002
- The Effects of Early Treatment, Lead Time and Length Bias on the Mortality Experienced by Cases Detected by ScreeningInternational Journal of Epidemiology, 1982
- A PECULIAR FORM OF PERIPHERAL NEUROPATHYBrain, 1952